These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33599731)

  • 21. Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment.
    de Nie I; de Blok CJM; van der Sluis TM; Barbé E; Pigot GLS; Wiepjes CM; Nota NM; van Mello NM; Valkenburg NE; Huirne J; Gooren LJG; van Moorselaar RJA; Dreijerink KMA; den Heijer M
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3293-9. PubMed ID: 32594155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent vaginal bleeding during gender-affirming hormone therapy in transgender men.
    da Silva ED; Spritzer PM; Fighera TM
    J Endocrinol Invest; 2024 Aug; 47(8):2053-2060. PubMed ID: 38300501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical changes, laboratory parameters, and bone mineral density during testosterone treatment in adolescents with gender dysphoria.
    Stoffers IE; de Vries MC; Hannema SE
    J Sex Med; 2019 Sep; 16(9):1459-1468. PubMed ID: 31405768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis.
    Ruggeri M; Tosetto A; Frezzato M; Rodeghiero F
    Ann Intern Med; 2003 Sep; 139(6):470-5. PubMed ID: 13679323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Estrone in Feminizing Hormone Treatment.
    Tebbens M; Heijboer AC; T'Sjoen G; Bisschop PH; den Heijer M
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e458-e466. PubMed ID: 34632510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
    Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
    Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender-affirming hormone treatment and cognitive function in transgender young adults: a systematic review and meta-analysis.
    Karalexi MA; Georgakis MK; Dimitriou NG; Vichos T; Katsimpris A; Petridou ET; Papadopoulos FC
    Psychoneuroendocrinology; 2020 Sep; 119():104721. PubMed ID: 32512250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treating transgender minors with hormones: obstacles in medical ethics today].
    Bernier A; Leplège A
    Med Sci (Paris); 2018; 34(6-7):595-598. PubMed ID: 30067215
    [No Abstract]   [Full Text] [Related]  

  • 29. Response to Letter to the Editor From Laidlaw: "Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-term Follow-up Study on Prevalence, Determinants, and Exposure Years".
    Madsen MC; van Dijk D; Wiepjes CM; Conemans EB; Thijs A; den Heijer M
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4791-e4792. PubMed ID: 34282457
    [No Abstract]   [Full Text] [Related]  

  • 30. Letter to the Editor from Giovanelli and Quinton: "Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: a Long-Term Follow-up Study on Prevalence, Determinants, and Exposure Years".
    Giovanelli L; Quinton R
    J Clin Endocrinol Metab; 2022 Jan; 107(1):e440-e441. PubMed ID: 34387315
    [No Abstract]   [Full Text] [Related]  

  • 31. [Sex/gender ratio of adolescents with gender dysphoria of the Gender Identity Treatment Unit of Asturias].
    Fernández Rodríguez M; Guerra Mora P; Revuelta Fernández AI; Villaverde González A
    Rev Int Androl; 2021; 19(3):195-200. PubMed ID: 32624407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender-affirming hormone treatment modalities for transfemale & non-binary transfeminine individuals: A UK perspective.
    Sagar RC; Millson-Brown V
    Best Pract Res Clin Endocrinol Metab; 2024 Sep; 38(5):101921. PubMed ID: 39232976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory Changes During Gender-Affirming Hormone Therapy in Transgender Adolescents.
    Millington K; Lee JY; Olson-Kennedy J; Garofalo R; Rosenthal SM; Chan YM
    Pediatrics; 2024 May; 153(5):. PubMed ID: 38567424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone.
    Oakes M; Arastu A; Kato C; Somers J; Holly HD; Elstrott BK; Dy GW; Kohs TCL; Patel RR; McCarty OJT; DeLoughery TG; Milano C; Raghunathan V; Shatzel JJ
    Thromb Res; 2021 Nov; 207():96-98. PubMed ID: 34592628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging Male.
    Jones SD; Dukovac T; Sangkum P; Yafi FA; Hellstrom WJ
    Sex Med Rev; 2015 Apr; 3(2):101-112. PubMed ID: 27784544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of testosterone therapy on personality traits of trans men: a controlled prospective study in Germany and Switzerland.
    Metzger NY; Boettger S
    Psychiatry Res; 2019 Jun; 276():31-38. PubMed ID: 30999214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Comparison of Secondary Polycythemia in Hypogonadal Men Treated with Clomiphene Citrate versus Testosterone Replacement: A Multi-Institutional Study.
    Wheeler KM; Smith RP; Kumar RA; Setia S; Costabile RA; Kavoussi PK
    J Urol; 2017 Apr; 197(4):1127-1131. PubMed ID: 27984109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review.
    Velho I; Fighera TM; Ziegelmann PK; Spritzer PM
    Andrology; 2017 Sep; 5(5):881-888. PubMed ID: 28709177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematocrit Response and Risk Factors for Significant Hematocrit Elevation with Implantable Testosterone Pellets.
    Hayden RP; Bennett NE; Tanrikut C
    J Urol; 2016 Dec; 196(6):1715-1720. PubMed ID: 27287525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time Course of Body Composition Changes in Transgender Adolescents During Puberty Suppression and Sex Hormone Treatment.
    Boogers LS; Reijtenbagh SJP; Wiepjes CM; van Trotsenburg ASP; den Heijer M; Hannema SE
    J Clin Endocrinol Metab; 2024 Jul; 109(8):e1593-e1601. PubMed ID: 38128064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.